Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Wed, 20.11.2024
Vidac Pharma Holding Plc
Company Name:
Vidac Pharma Holding Plc
ISIN:
GB00BM9XQ619
Reason for the research:
Update Report
Recommendation:
Buy
from:
20.11.2024
Target price:
EUR 4.90 (unchanged)
Target price on sight of:
36 months
Last rating change:
-
Analyst:
Peter Thilo Hasler
Vidac Pharma has been granted a broad and exclusive patent by the United [ … ]
Thu, 06.06.2024
Almonty Industries Inc.
Defence spendings drive tungsten demand
As geopolitical tensions continue to rise, the demand for advanced defence
technologies is likely to increase, driving the demand for tungsten armour
which is less regulated than depleted uranium and also considered
“exportable” by the US government. With the world’s longest produci [ … ]
Tue, 06.02.2024
Ikonisys SA
Creating a leading player in cancer diagnostics
Only weeks after Ikonisys entered a strategic partnership with Biocare
Medical, the company made the next strategic step in business development
by announcing the takeover of Hospitex, an Italian-based cytology company
specialising in oncological diagnostics. According to the company, Hospite [ … ]
Mon, 15.01.2024
Eloro Resources Ltd.
New intersections highlight potential for extraordinary grades
Eloro Resources intersected the highest-grade silver sample at Iska Iska so
far, confirming the strategy adopted by the Board of Directors to expand
and upgrade the high-grade area of the Santa Barbara Breccia Pipe in
particular. With mineralised intercepts of up to 118.86 g Ag [ … ]
Thu, 14.12.2023
Rover Metals Corp.
Cabin Lake offered for sale – Focus on Lithium assets
With a strict focus on the Let’s Go Lithium project in Nevada and the IML
project in the Northwest Territories, Rover Metals has announced that it
intends to offer its 100% owned Cabin Lake gold project for sale. Located
110 km northwest of Yellowknife at the northern end of [ … ]
Wed, 01.11.2023
Ikonisys SA
Strategic alliance with Biocare Medical is a game changer
Ikonisys announced that it has entered a strategic partnership with Biocare
Medical which will take advantage of each firm’s respective strengths to
drive and deepen their leading-edge technology positions. Ikonisys, in
addition, will substantially expand its global footprint [ … ]
Mon, 23.10.2023
Eloro Resources Ltd.
The importance of ore sorting and stripping ratios
After Eloro Resources published the initial mineral resource estimate (MRE)
for the Iska Iska silver-tin polymetallic project in the Bolivian Potosi
Department, the share price came under significant pressure. We believe
this was based on certain misconceptions specifically about the impac [ … ]
Wed, 18.10.2023
Rover Metals Corp.
Upgrading LGL’s project size to 33.6 sq km
After the acquisition of a further 2,400 acres, significantly enhancing the
total project size of Rover Metals’ most promising asset Let’s Go Lithium
(LGL) to approximately 8,300 acres or 33.6 sq km, we reiterate our Buy
rating for the shares of Rover Metals. However, the signifi [ … ]
Fri, 18.08.2023
Almonty Industries Inc.
H1/2023 in-line with estimates – Los Santos about to reopen
With CAD 12.6mn and CAD -3.8mn, both sales (H1/2022 CAD 13.3mn) and pre-tax
loss (H1/2022: CAD -3.9mn), respectively, were in-line with our
expectations in H1/2023. 100% of revenues were generated by the Portuguese
Panasqueira mine, where ore mined and processed declined by [ … ]
Thu, 03.08.2023
Rover Metals Corp.
Let’s Go, Rover, Let’s Go!
We initiate research coverage of Rover Metals with a Buy rating and a price
target of CAD 0.92 per share, representing substantial upside from the
current share price, and highlight that the current pullback in the
company’s stock price (during its recent financing rounds) could be an
interestin [ … ]